# James P. Lin, M.D., Inc. – FDA Inspection, Mar 5, 2020

Source: https://www.keypedia.com/records/fda_inspections/james-p-lin-md-inc/a2ea2f03-54aa-4b55-80a5-4d20da634552
Source feed: FDA_Inspections

> FDA inspection 1120143 of James P. Lin, M.D., Inc., March 05, 2020. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120143
- Company Name: James P. Lin, M.D., Inc.
- Inspection Date: 2020-03-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1247157 - 2024-08-22](https://www.keypedia.com/records/fda_inspections/james-p-lin-md-inc/e757db1e-9818-413c-a4c6-0b8a1b57a309)

Company: https://www.keypedia.com/companies/james-p-lin-md-inc/b180b349-824b-4a17-b778-d3dcbf062120

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d